Reuters logo
BRIEF-Reata provides update on Bardoxolone Methyl from American Society of Nephrology Kidney Week Meeting
November 6, 2017 / 12:52 PM / a month ago

BRIEF-Reata provides update on Bardoxolone Methyl from American Society of Nephrology Kidney Week Meeting

Nov 6 (Reuters) - Reata Pharmaceuticals Inc:

* Reata provides update on bardoxolone methyl from the american society of nephrology kidney week meeting

* Reata pharmaceuticals - activation of sites in phoenix phase 2 program to study bardoxolone in patients with other rare forms of chronic kidney disease

* Reata pharmaceuticals says anticipates that data from individual cohorts of phoenix will be released throughout second half of 2018 and 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below